Sarah Perales
Nurse Practitioner · San Antonio, TXNPI 1538787478
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 85 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 20.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $1,035 and has fallen 91.1% since, to $92 in 2025.
Across 85 payments — averaging $20.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$352
- AbbVie$245
- Lilly USA, LLC$237
- Dexcom, Inc.$97
- Exact Sciences$95
- AstraZeneca$89
- plus $629 from 21 others
What the payments were for
- Food & beverage$1,744100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 15 | $352 |
| AbbVie | 10 | $245 |
| Lilly USA, LLC | 14 | $237 |
| Dexcom, Inc. | 6 | $97 |
| Exact Sciences | 4 | $95 |
| AstraZeneca | 5 | $89 |
| GSK | 4 | $72 |
| Pfizer | 3 | $61 |
| Axsome Therapeutics, Inc. | 2 | $50 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $44 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| Astellas Pharma US Inc | 2 | $31 |
| Insulet Corporation | 2 | $31 |
| Sanofi Pasteur Inc. | 1 | $30 |
| Ironwood Pharmaceuticals, Inc | 1 | $27 |
| Esperion Therapeutics, Inc. | 1 | $25 |
| Philips North America LLC | 1 | $24 |
| Noven Therapeutics, LLC | 1 | $23 |
| Phadia US Inc. | 1 | $22 |
| Boehringer Ingelheim | 1 | $22 |
| Novartis | 1 | $21 |
| Cequr Corporation | 1 | $20 |
| Lundbeck LLC | 1 | $19 |
| Ironshore Pharmaceuticals Inc. | 1 | $19 |
| Amarin Pharma, Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Wegovy$125
How this compares
$1,744 in reported general payments places this provider in the 80th percentile of 5,422 nurse practitioner providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $275 |
| Atorvastatin Calcium | 23 | $165 |
| Levothyroxine Sodium | 13 | $129 |
| Lisinopril | 12 | $81 |
| Hydrochlorothiazide | 20 | $57 |
| Metformin Hcl | 11 | $50 |
| Methylprednisolone | 11 | $38 |
| Amlodipine Besylate | 13 | $29 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in San Antonio
- Corrie BerkSan Antonio$155K
- Sonja BruneSan Antonio$51K
- Laura GalvanSan Antonio$32K
- Eduardo GonzalezSan Antonio$32K
- Roberta RomeroSan Antonio$26K
- Christopher GarciaSan Antonio$21K
- Jennifer ZavalaSan Antonio$17K
- Amy RivasSan Antonio$17K
- Alexis WahlenSan Antonio$16K
- Cecilia DavisAustin$262K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.